Wells Fargo raised the firm’s price target on Doximity to $27 from $25 and keeps an Equal Weight rating on the shares. The company’s fiscal Q3 beat helps raise estimates and early data on the new portal and go-to-market changes “appears promising,” the analyst tells investors in a research note. However, the firm says it is unlikely to be a “silver bullet for revenue acceleration.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DOCS: